Terms: = Leukemia AND NCOR1, hCIT529I10, 9611, ENSG00000141027, N-CoR, MGC104216, TRAC1, O75376, hN-CoR, KIAA1047 AND Treatment
10 results:
1. [Study of a patient with Myelodysplastic/myeloproliferative neoplasm with co-morbid neutrophilia and a novel ncor1::GLYR1 fusion gene].
Lei Y; Zhao X; Zhao H; Cheng Y; Wang S; Li J; Zhu Y
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2024 Apr; 41(4):404-410. PubMed ID: 38565504
[TBL] [Abstract] [Full Text] [Related]
2. Clinical and demographic factors contributing to asparaginase-associated toxicities in children with acute lymphoblastic leukemia.
Dharia P; Swartz MD; Bernhardt MB; Chen H; Gramatges MM; Lupo PJ; Brown AL; Scheurer ME
Leuk Lymphoma; 2022 Dec; 63(12):2948-2954. PubMed ID: 35895075
[TBL] [Abstract] [Full Text] [Related]
3. Genome-wide co-occupancy of AML1-ETO and n-cor defines the t(8;21) AML signature in leukemic cells.
Trombly DJ; Whitfield TW; Padmanabhan S; Gordon JA; Lian JB; van Wijnen AJ; Zaidi SK; Stein JL; Stein GS
BMC Genomics; 2015 Apr; 16(1):309. PubMed ID: 25928846
[TBL] [Abstract] [Full Text] [Related]
4. Novel treatment of acute promyelocytic leukemia: As₂O₃, retinoic acid and retinoid pharmacology.
Zhu G
Curr Pharm Biotechnol; 2013; 14(9):849-58. PubMed ID: 24433507
[TBL] [Abstract] [Full Text] [Related]
5. HOXC6 Is transcriptionally regulated via coordination of MLL histone methylase and estrogen receptor in an estrogen environment.
Ansari KI; Hussain I; Shrestha B; Kasiri S; Mandal SS
J Mol Biol; 2011 Aug; 411(2):334-49. PubMed ID: 21683083
[TBL] [Abstract] [Full Text] [Related]
6. CREBBP mutations in relapsed acute lymphoblastic leukaemia.
Mullighan CG; Zhang J; Kasper LH; Lerach S; Payne-Turner D; Phillips LA; Heatley SL; Holmfeldt L; Collins-Underwood JR; Ma J; Buetow KH; Pui CH; Baker SD; Brindle PK; Downing JR
Nature; 2011 Mar; 471(7337):235-9. PubMed ID: 21390130
[TBL] [Abstract] [Full Text] [Related]
7. The ETO (MTG8) gene family.
Davis JN; McGhee L; Meyers S
Gene; 2003 Jan; 303():1-10. PubMed ID: 12559562
[TBL] [Abstract] [Full Text] [Related]
8. Cell signaling switches HOX-PBX complexes from repressors to activators of transcription mediated by histone deacetylases and histone acetyltransferases.
Saleh M; Rambaldi I; Yang XJ; Featherstone MS
Mol Cell Biol; 2000 Nov; 20(22):8623-33. PubMed ID: 11046157
[TBL] [Abstract] [Full Text] [Related]
9. The impact of differential binding of wild-type RARalpha, PML-, PLZF- and NPM-RARalpha fusion proteins towards transcriptional co-activator, RIP-140, on retinoic acid responses in acute promyelocytic leukemia.
So CW; Dong S; So CK; Cheng GX; Huang QH; Chen SJ; Chan LC
Leukemia; 2000 Jan; 14(1):77-83. PubMed ID: 10637480
[TBL] [Abstract] [Full Text] [Related]
10. Reduced retinoic acid-sensitivities of nuclear receptor corepressor binding to PML- and PLZF-RARalpha underlie molecular pathogenesis and treatment of acute promyelocytic leukemia.
Guidez F; Ivins S; Zhu J; Söderström M; Waxman S; Zelent A
Blood; 1998 Apr; 91(8):2634-42. PubMed ID: 9531570
[TBL] [Abstract] [Full Text] [Related]